Form 4 for SPRY ARS Pharmaceuticals, Inc.

Accepted 2023-10-02 00:00:00 ET · period of report 2023-09-28 · accession 0001209191-23-051073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-10-02	2023-09-28+	SPRY	Fitzpatrick Alexander A	CLO	P - Purchase	$3.71	+86.3K	43.0K	New	+$319.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-09-29	P	A	46,258	$3.78	89,227	D	—	—	(F3) The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
2	Common	Common Stock	2023-09-28	P	A	40,000	$3.62	42,969	D	—	—	(F1) The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.64, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. (F2) Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2023.